Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart. (2020)
Attributed to:
Developing chemical mass spectrometry probes to assess the production of reactive oxygen species in vivo
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10557-020-07086-7
PubMed Identifier: 32979176
Publication URI: http://europepmc.org/abstract/MED/32979176
Type: Journal Article/Review
Volume: 34
Parent Publication: Cardiovascular drugs and therapy
Issue: 6
ISSN: 0920-3206